Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 12/20 | 0.67 |
| ▸ | NPY1R | P25929 | 7/20 | 0.67 |
| ▸ | NPY2R | P49146 | 5/20 | 0.67 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.60 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.57 |
| ▸ | NTSR2 | O95665 | 2/20 | 0.56 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3649802 | 1.00 | NPY4R (0.67) | NPY4RNPY1RNPY2RNPY5ROPRK1 | |
| SCHEMBL6131648 | 0.95 | OPRK1 (0.60) | NPY4RNPY1RNPY2RNPY5ROPRK1 | |
| SCHEMBL2064607 | 0.95 | NPY4R (0.58) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| SCHEMBL6131647 | 0.95 | OPRK1 (0.60) | NPY4RNPY1RNPY2RNPY5ROPRK1 | |
| SCHEMBL2064604 | 0.95 | NPY4R (0.58) | NPY4RNPY1RNPY2RNPY5ROPRM1 | |
| SCHEMBL9197350 | 0.94 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5ROPRK1 | |
| SCHEMBL413803 | 0.91 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5ROPRK1 | |
| SCHEMBL413804 | 0.91 | NPY4R (0.56) | NPY4RNPY1RNPY2RNPY5ROPRK1 | |
| SCHEMBL29770017 | 0.91 | NTSR2 (0.68) | NPY4RNPY1RNPY2RNPY5ROPRK1 | |
| SCHEMBL30471386 | 0.91 | NPY4R (0.76) | NPY4RNPY1RNPY2RNPY5ROPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2173753-A2 | LABELLING METHODS | GE Healthcare UK Limited (GB) | 2010-04-14 | — | — | EP | disclosed |
| WO-2008155339-A2 | LABELLING METHODS | GE HEALTHCARE LIMITED (GB) | 2008-12-24 | — | — | WO | disclosed |
| EP-0732944-A4 | LABELED CHEMOTACTIC PEPTIDES TO IMAGE FOCAL SITES OF INFECTION OR INFLAMMATION | GEN HOSPITAL CORP (US) | 2000-06-07 | — | — | EP | disclosed |
| EP-0732944-A1 | LABELED CHEMOTACTIC PEPTIDES TO IMAGE FOCAL SITES OF INFECTION OR INFLAMMATION | THE GENERAL HOSPITAL CORPORATION (US) | 1996-09-25 | — | — | EP | disclosed |
| WO-1995011045-A1 | LABELED CHEMOTACTIC PEPTIDES TO IMAGE FOCAL SITES OF INFECTION OR INFLAMMATION | THE GENERAL HOSPITAL CORPORATION (US) | 1995-04-27 | — | — | WO | disclosed |